预测主动脉瓣置换术后30天死亡的新综合工具
基于多中心OBSERVANT研究4718例患者,开发并验证了纳入衰弱评估的OBS AVR风险评分,用于预测外科主动脉瓣置换术后30天死亡。该评分在区分度和校准度上均优于EuroSCORE II,并与5年死亡率显著相关。
要点
- OBS AVR评分纳入年龄、COPD、合并冠脉血运重建、衰弱分层、急诊手术和eGFR。
- OBS AVR评分区分度(AUC 0.76 vs 0.70)和校准度均优于EuroSCORE II。
- OBS AVR评分与5年死亡率显著相关,随评分十分位数增加而升高。
核心结论
- OBS AVR风险评分在预测外科主动脉瓣置换术后30天死亡率方面具有较高的区分度和校准度。
- 将简化衰弱评估加入模型似乎有助于提高对EuroSCORE II的预测能力。
- OBS AVR风险评分与长期死亡率显著相关。
研究设计与样本
- 多中心OBSERVANT研究共纳入4718例患者,分为推导队列(n=3539)和验证队列(n=1179)。
- 采用逐步logistic回归和基于Akaike信息准则的变量选择方法筛选与30天死亡率相关的变量。
- 将回归模型性能与EuroSCORE II进行比较。
主要发现
- 30天时,推导数据集和验证数据集分别有90例(2.54%)和35例(2.97%)患者死亡。
- 年龄、慢性阻塞性肺疾病、合并冠状动脉血运重建、按Geriatric Status Scale分层的衰弱、急诊手术和估算肾小球滤过率是30天死亡的独立预测因素。
- OBS AVR评分的区分度(AUC 0.76 vs 0.70,P < 0.001)和校准度(Hosmer-Lemeshow P = 0.847 vs P = 0.130)均高于EuroSCORE II。
- 决策曲线、净重分类指数(0.46,P = 0.011)和综合判别改善(0.02,P < 0.001)分析证实了OBS AVR评分的更优性能。
- 5年死亡率随OBS AVR评分十分位数的增加而显著升高(P < 0.001)。
关键数值与推荐
- OBS AVR评分包含的预测变量:年龄、慢性阻塞性肺疾病、合并冠状动脉血运重建、按Geriatric Status Scale分层的衰弱、急诊手术和估算肾小球滤过率。
- OBS AVR评分AUC为0.76,EuroSCORE II为0.70(P < 0.001)。
- OBS AVR评分Hosmer-Lemeshow检验P = 0.847,EuroSCORE II为P = 0.130。
- 净重分类指数为0.46(P = 0.011),综合判别改善为0.02(P < 0.001)。
临床怎么用
- OBS AVR评分可用于外科主动脉瓣置换术后30天死亡风险的术前评估,尤其适用于纳入衰弱评估以改善风险分层。
- 该评分在区分度和校准度上优于EuroSCORE II,可作为EuroSCORE II的补充工具。
- OBS AVR评分与长期死亡率相关,可能有助于识别高风险患者以优化围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We sought to develop and validate a novel risk assessment tool for the prediction of 30-day mortality after surgical aortic valve replacement incorporating a patient's frailty. METHODS: Overall, 4718 patients from the multicentre study OBSERVANT was divided into derivation (n = 3539) and validation (n = 1179) cohorts. A stepwise logistic regression procedure and a criterion based on Akaike information criteria index were used to select variables associated with 30-day mortality. The performance of the regression model was compared with that of European System for Cardiac Operative Risk Evaluation (EuroSCORE) II. RESULTS: At 30 days, 90 (2.54%) and 35 (2.97%) patients died in the development and validation data sets, respectively. Age, chronic obstructive pulmonary disease, concomitant coronary revascularization, frailty stratified according to the Geriatric Status Scale, urgent procedure and estimated glomerular filtration rate were independent predictors of 30-day mortality. The estimated OBS AVR score showed higher discrimination (area under curve 0.76 vs 0.70, P < 0.001) and calibration (Hosmer-Lemeshow P = 0.847 vs P = 0.130) than the EuroSCORE II. The higher performances of the OBS AVR score were confirmed by the decision curve, net reclassification index (0.46, P = 0.011) and integrated discrimination improvement (0.02, P < 0.001) analyses. Five-year mortality increased significantly along increasing deciles of the OBS AVR score (P < 0.001). CONCLUSIONS: The OBS AVR risk score showed high discrimination and calibration abilities in predicting 30-day mortality after surgical aortic valve replacement. The addition of a simplified frailty assessment into the model seems to contribute to an improved predictive ability over the EuroSCORE II. The OBS AVR risk score showed a significant association with long-term mortality.
引用
- Biancari F, Rosato S, Costa G, et al. A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement. Eur J Cardiothorac Surg. 2021. PMID: 33575794. doi:10.1093/ejcts/ezaa375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。